Business Context and Reporting Period
This Form 8-K was filed by Tharimmune, Inc. (trading symbol: THAR) on September 2, 2025. The registrant is a Delaware corporation with principal executive offices in Red Bank, NJ, and is classified as an emerging growth company. The filing reports on executive compensation adjustments approved by the Compensation Committee on the date of the report.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on executive compensation changes rather than financial performance metrics.
Material Changes
The primary material change reported is an adjustment to the compensation packages for two key executives:
- Base Salary Increase: The base salary for CEO Sireesh Appajosyula and Executive Chairman Vincent LoPriore was increased by $100,000, bringing the new base salary to $385,000 for each.
- Change of Control Enhancement: The severance payment multiplier for termination within 12 months of a change of control was increased from two (2) times base salary and target bonus to three (3) times base salary and target bonus for both executives.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, outlook, management commentary on operations, specific risks, contingencies, or unusual items beyond the compensation adjustments described.
Investor Verification Checklist
- Verify the effective date of the salary increase and the specific terms of the new change of control provisions.
- Review the company's most recent 10-K or 10-Q to assess the impact of increased executive compensation on cash burn and liquidity.
- Confirm the current status of the company's emerging growth company designation and any related accounting election implications.